Peginesatide Side Effects
Medically reviewed by Drugs.com. Last updated on Mar 29, 2023.
Applies to peginesatide: injectable solution.
Cardiovascular
Cardiovascular side effects have included hypotension (14.2%), hypertension (13.2%), and procedural hypotension (10.9%).[Ref]
Gastrointestinal
Gastrointestinal side effects have included diarrhea (18.4%), nausea (17.4%), and vomiting (15.3%).[Ref]
General
General side effects have included pyrexia (12.2%).[Ref]
Immunologic
Immunologic side effects have included the development of peginesatide specific antibodies (1.2%).[Ref]
Metabolic
Metabolic side effects have included hyperkalemia (11.4%).[Ref]
Musculoskeletal
Musculoskeletal side effects have included muscle spasms (15.3%), pain in extremity (10.9%), back pain (10.9%), and arthralgia (10.7%).[Ref]
Nervous system
Nervous system side effects have included headache (15.4%).[Ref]
Other
Other side effects have included arteriovenous fistula site complication (16.1%).[Ref]
Respiratory
Respiratory side effects have included dyspnea (18.4%), cough (15.9%), and upper respiratory infection (11.0%).[Ref]
Hypersensitivity
Hypersensitivity side effects have included postmarketing reports of serious allergic reactions including fatal reactions (0.02%).
More about peginesatide
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: recombinant human erythropoietins
- Breastfeeding
Patient resources
Other brands
Related treatment guides
References
1. Product Information. Omontys (peginesatide). Takeda Pharmaceuticals America. 2012.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.